Artificial Intelligent (AI) and Machine Learning (ML) are developing significant advances and gaining importance information processing in a huge number of fields such as chemical, pharmaceutical, biological etc. The Perturbation Theory (PT) is commonly combined with ML in order to generate PTML models and has been used in various disciplines to predict the biological activity of drugs and nanoparticles. In addition, this powerful tool has showed promising results in the field of nanoinformatics. As a consequence of evident achievements on a wide range of predictive tasks, ML techniques are attracting significant interest across a variety of stakeholders. Therefore, In this review different type of application of machine learning in nanoparticles involve in neurological diseases will be discussed.
In addition, different startup, spin-off, Small and Medium Enterprises (SMEs), and also some BigPharman, Tech companies, Nanoform-Drug Particle Engineering, Precision Medicine, NanosticsNanotechnology-Baed Diagnostic etc. are developing AI-based nanomedicine, nanotechnology, brain diseases so on. This communication also lists some of these startup companies.